Here’s how French pharmaceutical giant Sanofi-Aventis SA, which has initiated a hostile takeover attempt for Genzyme Corp. of Cambridge, Mass., describes how the proposed $18.5 billion deal would benefit the two companies and their shareholders:
See the original post here:
How Sanofi sees benefits of Genzyme takeover
Popular Posts:
- Health Plan Week Finds Cigna Corp. CEO Had the Highest Total Compensation Package of Any Publicly Traded Health Insurer CEO in 2011
- Corporate Whistle Blower Center Urges Healthcare Medical Device & Pharmaceutical Executives to Step Forward for Huge Rewards if They Can Prove Multi Million Dollar Fraud
- Know the Truth about the Government Health Care Bill HR 3200-Key Points.flv
- Geron shares rise on stem cell study
- Geron shares rise on stem cell study